Sponsored by Emory University
The purpose of the study is to find out if trastuzumab alone or trastuzumab in combination with everolimus is effective in metastatic breast cancers that are no longer controlled by hormonal therapies.
Study Start Date: May 2009
Estimated Completion Date: October 2016
Specialties: Obstetrics & Gynecology: Breast,Clinical Pharmacology Oncology: Breast,Pharmacology/Therapy Pharmacy: Chemotherapy/Oncology Physician Assistant: Clinical Pharmacology,Hematology/Oncology
Get your trial in front of 1000s of physicians and patients.
Visit ClinicalTrialsLocator.com to find out how you can feature this clinical trial.
Don't Have Account? Sign Up here.
Enter your email address and a password reset email will be sent to you.
Please submit one of the following:
— Action Required —
Your browser is currently blocking ads. We depend on ad sponsorships in order to keep this site free to the healthcare provider community. Help us keep this site free by turning off your ad blocker.
Turn Off Ad Blocker
We have detected that you are currently blocking ads. We kindly ask that you enable ads when visiting our site. We depend on ad sponsorships in order to keep this site free to the healthcare provider community.